Sentiment-Signal
33,7
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
64
2 neu, 5 erhöht, -481210K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 10.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ¨ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 29.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ay differ materially from these estimates. Item 5.02 Departure of Directors or Certain Officers; Election of Directors |
| 05.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 12.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 20.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 22.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 11.04.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Unternehmen & Branche
| Name | IRONWOOD PHARMACEUTICALS INC |
|---|---|
| Ticker | IRWD |
| CIK | 0001446847 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 46333X108 |
|---|---|
| ISIN | US46333X1081 |
| Typ | Common Stock |
| Marktkapitalisierung | 718,3 Mio. USD |
| Beta | 0,17 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 47,709,000 | -2,276,000 | -0.01 | 396,901,000 | -261,835,000 |
| 2025-09-30 | 10-K | 122,060,000 | 40,080,000 | 0.23 | ||
| 2025-09-30 | 10-Q | 122,060,000 | 40,080,000 | 0.23 | 396,062,000 | -264,157,000 |
| 2025-06-30 | 10-K | 85,239,000 | 23,599,000 | 0.14 | ||
| 2025-06-30 | 10-Q | 85,239,000 | 23,599,000 | 0.14 | 342,946,000 | -308,162,000 |
| 2025-03-31 | 10-Q | 41,143,000 | -37,386,000 | -0.23 | 327,213,000 | -334,053,000 |
| 2025-03-31 | 10-K | 41,143,000 | -37,386,000 | -0.23 | ||
| 2024-12-31 | 10-K | 90,545,000 | 2,256,000 | 0.01 | 350,908,000 | -301,335,000 |
| 2024-09-30 | 10-Q | 91,592,000 | 3,646,000 | 0.02 | 389,519,000 | -311,334,000 |
| 2024-09-30 | 10-K | 91,592,000 | 3,646,000 | 0.02 | ||
| 2024-06-30 | 10-Q | 94,396,000 | -860,000 | -0.01 | 395,620,000 | -321,727,000 |
| 2024-06-30 | 10-K | 94,396,000 | -860,000 | -0.01 | ||
| 2024-03-31 | 10-Q | 74,877,000 | -4,162,000 | -0.03 | 438,819,000 | -330,518,000 |
| 2024-03-31 | 10-K | 74,877,000 | -4,162,000 | -0.03 | ||
| 2023-12-31 | 10-K | 117,553,000 | -1,087,000 | -0.01 | 471,073,000 | -346,295,000 |
| 2023-09-30 | 10-Q | 113,739,000 | 15,321,000 | 0.09 | 524,063,000 | -323,216,000 |
| 2023-09-30 | 10-K | 113,739,000 | 15,321,000 | 0.09 | ||
| 2023-06-30 | 10-K | 107,382,000 | -1,062,187,000 | -6.84 | ||
| 2023-06-30 | 10-Q | 107,382,000 | -1,062,187,000 | -6.84 | 603,220,000 | -345,704,000 |
| 2023-03-31 | 10-K | 104,061,000 | 45,714,000 | 0.25 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 15,958,196 | 0 | 15,958,196 | 53,779,120 | Neu | +100,0% | |
| UBS Group AG | 14,703,545 | 11,710,863 | 2,992,682 | 45,084,213 | Aufgestockt | +25,6% | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 46,942,000 | 0 | 46,942,000 | 44,735,726 | Neu | +100,0% | |
| BlackRock, Inc. | 12,784,806 | 0 | 12,784,806 | 43,084,796 | Neu | +100,0% | |
| Context Capital Management, LLC | 42,119,000 | 0 | 42,119,000 | 39,802,455 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 11,521,660 | 0 | 11,521,660 | 38,827,995 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 8,204,973 | 0 | 8,204,973 | 27,650,759 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4,975,939 | 0 | 4,975,939 | 16,768,914 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 4,723,531 | 0 | 4,723,531 | 15,918,299 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 4,424,002 | 0 | 4,424,002 | 14,908,888 | Neu | +100,0% | |
| STATE STREET CORP | 4,411,222 | 0 | 4,411,222 | 14,865,818 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,623,534 | 0 | 3,623,534 | 12,213,817 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 11,767,446 | 0 | 11,767,446 | 11,422,518 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 2,853,205 | 0 | 2,853,205 | 9,615,301 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 2,836,462 | 0 | 2,836,462 | 9,558,877 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,759,667 | 0 | 2,759,667 | 9,300,078 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 2,082,055 | 330,836 | 1,751,219 | 7,306,566 | Aufgestockt | +529,3% | |
| Chicago Capital Management, LLC | 7,000 | 4,000 | 3,000 | 6,908,417 | Aufgestockt | +75,0% | |
| Connor, Clark & Lunn Investment Management Ltd. | 1,990,927 | 0 | 1,990,927 | 6,709,424 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 1,681,229 | 0 | 1,681,229 | 5,665,742 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,275,315 | 0 | 1,275,315 | 4,297,812 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,233,685 | 0 | 1,233,685 | 4,157,518 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 1,109,924 | 0 | 1,109,924 | 3,740,444 | Neu | +100,0% | |
| LAZARD ASSET MANAGEMENT LLC | 1,000,445 | 0 | 1,000,445 | 3,371,500 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 869,826 | 0 | 869,826 | 2,931,314 | Neu | +100,0% | |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3,000,000 | 0 | 3,000,000 | 2,837,126 | Neu | +100,0% | |
| MORGAN STANLEY | 739,685 | 0 | 739,685 | 2,492,739 | Neu | +100,0% | |
| FMR LLC | 686,737 | 0 | 686,737 | 2,314,305 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 673,862 | 0 | 673,862 | 2,270,914 | Neu | +100,0% | |
| IEQ CAPITAL, LLC | 633,260 | 0 | 633,260 | 2,134,086 | Neu | +100,0% | |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 540,492 | 0 | 540,492 | 1,897,127 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 560,713 | 0 | 560,713 | 1,889,603 | Neu | +100,0% | |
| Inspire Investing, LLC | 509,941 | 0 | 509,941 | 1,789,893 | Neu | +100,0% | |
| Walleye Capital LLC | 527,936 | 0 | 527,936 | 1,779,144 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 515,299 | 0 | 515,299 | 1,736,557 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 503,942 | 0 | 503,942 | 1,698,284 | Neu | +100,0% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 495,993 | 0 | 495,993 | 1,671,496 | Neu | +100,0% | |
| Range Financial Group LLC | 433,256 | 426,095 | 7,161 | 1,520,729 | Aufgestockt | +1,7% | |
| Invesco Ltd. | 449,219 | 0 | 449,219 | 1,513,867 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 412,061 | 0 | 412,061 | 1,388,646 | Neu | +100,0% | |
| BARCLAYS PLC | 392,904 | 0 | 392,904 | 1,324,086 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 385,583 | 0 | 385,583 | 1,299,415 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 371,769 | 0 | 371,769 | 1,252,861 | Neu | +100,0% | |
| Robeco Institutional Asset Management B.V. | 342,998 | 342,998 | 0 | 1,203,923 | Unverändert | 0,0% | |
| JPMORGAN CHASE & CO | 515,607 | 0 | 515,607 | 1,010,079 | Neu | +100,0% | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 290,278 | 0 | 290,278 | 978,237 | Neu | +100,0% | |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 634,331 | 0 | 634,331 | 951,498 | Neu | +100,0% | |
| Russell Investments Group, Ltd. | 261,789 | 265,357 | -3,568 | 915,107 | Reduziert | -1,3% | |
| GROUP ONE TRADING LLC | 251,300 | 0 | 251,300 | 846,881 | Neu | +100,0% | |
| Nuveen, LLC | 233,412 | 139,487 | 93,925 | 819,276 | Aufgestockt | +67,3% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-04-07 | 4.292 | 3,53 | 15.151 |
| 2026-04-01 | 2.057 | 3,51 | 7.220 |
| 2026-03-11 | 12.573 | 3,70 | 46.520 |
| 2026-03-02 | 3.176 | 3,42 | 10.862 |
| 2026-02-26 | 1.083 | 3,36 | 3.639 |
| 2026-02-19 | 71 | 4,78 | 339 |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| UBS Group AG | 14,703,545 | 45,084,213 | 62.88 |
| DIMENSIONAL FUND ADVISORS LP | 2,082,055 | 7,306,566 | 10.19 |
| Chicago Capital Management, LLC | 7,000 | 6,908,417 | 9.64 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 540,492 | 1,897,127 | 2.65 |
| Inspire Investing, LLC | 509,941 | 1,789,893 | 2.50 |
| Range Financial Group LLC | 433,256 | 1,520,729 | 2.12 |
| Robeco Institutional Asset Management B.V. | 342,998 | 1,203,923 | 1.68 |
| Russell Investments Group, Ltd. | 261,789 | 915,107 | 1.28 |
| Nuveen, LLC | 233,412 | 819,276 | 1.14 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 226,688 | 740,884 | 1.03 |
| KLP KAPITALFORVALTNING AS | 174,200 | 611,442 | 0.85 |
| STRS OHIO | 97,400 | 341,874 | 0.48 |
| RITHOLTZ WEALTH MANAGEMENT | 87,535 | 307,248 | 0.43 |
| Pallas Capital Advisors LLC | 80,567 | 282,790 | 0.39 |
| SmartHarvest Portfolios, LLC | 75,462 | 264,872 | 0.37 |
| Merit Financial Group, LLC | 54,707 | 192,022 | 0.27 |
| Police & Firemen's Retirement System of New Jersey | 44,115 | 154,844 | 0.22 |
| Krilogy Financial LLC | 33,194 | 143,730 | 0.20 |
| HSBC HOLDINGS PLC | 29,706 | 103,971 | 0.15 |
| China Universal Asset Management Co., Ltd. | 28,936 | 101,565 | 0.14 |